Home NDC 54809-1024-8 54809-1024-8
Product NDC 54809-1024
Requested package NDC 54809-1024-8
11-digit product format 548091024
Labeler code 54809
Product ID 54809-1024_4e6c02cd-dcf0-271e-e063-6394a90a2f71
Type BULK INGREDIENT
Nonproprietary name Pancrelipase
Dosage form CAPSULE, DELAYED RELEASE PELLETS
Marketing category EXPORT ONLY
Marketing start 2013-10-21
Substance PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE
Active strength 12000 [USP'U]/1; 38000 [USP'U]/1; 60000 [USP'U]/1
Listing certified through 2027-12-31
Current FDA listing Yes
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 16 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 21:27 UTC · source 2025-12-05 a6255e0c9aa5…a0211a219f2e…2025-08-26 23:59 UTC · source 2025-08-26 1d862106b807…00c93037cd84…2025-05-15 14:59 UTC · source 2025-05-14 390b4c401c3f…2c692c2daee3…2025-04-01 07:37 UTC · source 2025-03-31 e30019b0c005…a3f0b14938b7…2025-03-01 13:19 UTC · source 2025-02-28 bbbc9f937eca…946b9c97cf81…2025-02-27 05:24 UTC · source 2025-02-26 f268b84574a6…26285f5ac5df…2025-02-01 13:13 UTC · source 2025-01-31 f764e8902f78…92046438deef…2025-01-20 13:05 UTC · source 2025-01-17 68b1e3bced9e…98a755eb8bc6…2024-11-29 20:42 UTC · source 2024-11-29 05c55d027831…ca05dca9dc4c…2024-11-09 02:36 UTC · source 2024-11-08 48b4f40e6753…c7c7a00d2afa…2024-10-09 02:27 UTC · source 2024-10-08 27f29a85d7e4…1372111e901f…2024-07-10 04:00 UTC · source 2024-07-09 8d62ce987f31…9fe9ef23e30d…2024-05-28 21:11 UTC · source 2024-05-28 d1e113ab4d42…063ee3eb0a1d…2024-05-15 03:51 UTC · source 2024-05-14 50b4072663b7…eae3003ed65e…2022-04-09 23:13 UTC · source 2022-04-08 906f6e251498…bf70b80e44f0…2021-12-27 23:28 UTC · source 2021-12-27 6db9cb8d1e19…3449e1ec5b70…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product No
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PANCRELIPASE LIPASE 12000 [USP'U]/1 PANCRELIPASE PROTEASE 38000 [USP'U]/1 PANCRELIPASE AMYLASE 60000 [USP'U]/1
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 54809-1024-8 Creon 12000 80000 in 1 DRUM CAPSULE, DELAYED RELEASE PELLETS 80000 16
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 54809-1024 CREON 24000 (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON 3000 (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON 6000 (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON 12000 (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS CREON 36000 (PANCRELIPASE) CAPSULE, DELAYED RELEASE PELLETS [ABBOTT LABORATORIES GMBH] 14 1 package rows 20241207_c29a4461-377f-402f-9f86-7b03f1be2aa4.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Status 54809-1024-8 54809102408 80000 CAPSULE, DELAYED RELEASE PELLETS in 1 DRUM (54809-1024-8) 07-DEC-21 Current